AKER: Final Settlement Hearing Rescheduled to December 20, 2019

NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that the hearing to determine whether to approve a proposed class action settlement that would benefit purchasers of Akers Biosciences, Inc. ("Akers") common stock  AKER, originally scheduled for November 8, 2019 at 2:30 p.m., has been rescheduled. The hearing will be held on December 20, 2019, at 11:00 a.m. before the Honorable Esther Salas, United States District Judge of the District of New Jersey, Martin Luther King Building & U.S. Courthouse, 50 Walnut Street, Courtroom MLK 5A, Newark, New Jersey 07102.

If you have any questions about the Settlement, you may call or write to Lead Counsel or to the Claims Administrator:

THE ROSEN LAW FIRM, P.A.

Laurence M. Rosen, Esq.

609 W. South Orange Avenue, Suite 2P

South Orange, NJ 07079

Tel: (973) 313-1887

Fax: (973) 833-0399

Akers Biosciences, Inc. Securities Litigation

c/o Strategic Claims Services

P.O. Box 230

600 N. Jackson St., Ste. 205

Media, PA 19063

Tel.:  866-274-4004

Fax:  610-565-7985  

info@strategicclaims.net

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsLegalPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!